Antimicrobial peptides: effectors of innate immunity in the skin (Q36340194)

13 August 2017

1 reference

title

Antimicrobial peptides: effectors of innate immunity in the skin (English)

1 reference

13 August 2017

main subject

antimicrobial peptide

1 reference

Orr Barak

1

1 reference

13 August 2017

James R Treat

series ordinal

2

1 reference

13 August 2017

William D James

series ordinal

3

1 reference

13 August 2017

publication date

1 January 2005

1 reference

13 August 2017

published in

Advances in dermatology

1 reference

13 August 2017

volume

21

1 reference

13 August 2017

page(s)

357-374

1 reference

Defensins: antimicrobial peptides of innate immunity

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

Immunology. Versatile defensins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

Can innate immunity be enhanced to treat microbial infections?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

Topical immunomodulators for the treatment of external genital warts, cutaneous warts and molluscum contagiosum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

Cathelicidin antimicrobial peptides are expressed in salivary glands and saliva

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

Cathelicidins, essential gene-encoded mammalian antibiotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

Cathelicidins: a novel protein family with a common proregion and a variable C‐terminal antimicrobial domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

Antimicrobial and Protease Inhibitory Functions of the Human Cathelicidin (hCAP18/LL-37) Prosequence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

Cathelicidins--a family of multifunctional antimicrobial peptides.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

Mechanisms of action of rabbit CAP18 on monolayers and liposomes made from endotoxins or phospholipids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

Evaluation of the effects of peptide antibiotics human beta-defensins-1/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

Innate antimicrobial peptide protects the skin from invasive bacterial infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

C-terminal domain of human CAP18 antimicrobial peptide induces apoptosis in oral squamous cell carcinoma SAS-H1 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

Mammalian defensins in immunity: more than just microbicidal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

Expression of natural peptide antibiotics in human skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

Expression of the peptide antibiotics human beta defensin-1 and human beta defensin-2 in normal human skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

Epithelial antibiotics induced at sites of inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

A peptide antibiotic from human skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

Endogenous antimicrobial peptides and skin infections in atopic dermatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

Reduced antimicrobial peptide expression in human burn wounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

Expression of human beta-defensins HBD-1, HBD-2, and HBD-3 in cultured keratinocytes and skin substitutes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

In human epidermis, beta-defensin 2 is packaged in lamellar bodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

Roles of antimicrobial peptides such as defensins in innate and adaptive immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

Human beta defensin-1 and -2 expression in human pilosebaceous units: upregulation in acne vulgaris lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

The time-dependent expression of fibronectin, MRP8, MRP14 and defensin in surgically treated human skin wounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

Human beta defensin is absent in burn blister fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

Antimicrobial Peptides in Health and Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

Dermcidin: a novel human antibiotic peptide secreted by sweat glands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

Dermcidin is constitutively produced by eccrine sweat glands and is not induced in epidermal cells under inflammatory skin conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

A neural survival factor is a candidate oncogene in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

alpha2-Macroglobulin-proteinase complexes protect Streptococcus pyogenes from killing by the antimicrobial peptide LL-37.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

Isolation of polymyxin B-susceptible mutants of Burkholderia pseudomallei and molecular characterization of genetic loci involved in polymyxin B resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

Bacterial evasion of innate host defenses--the Staphylococcus aureus lesson

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

Characterization of defensin resistance phenotypes associated with mutations in the phoP virulence regulon of Salmonella typhimurium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

Porcine polymorphonuclear leukocytes generate extracellular microbicidal activity by elastase-mediated activation of secreted proprotegrins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

inferred from DOI database lookup

7 January 2021

based on heuristic

Detection of dermcidin-derived peptides in sweat by ProteinChip technology

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2005.07.001

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YADR.2005.07.001

1 reference

13 August 2017

1 reference